Racial disparities in asthma-related health outcomes in severe or difficult-to-treat asthma (Q44345938)

2 December 2017

title

Racial disparities in asthma-related health outcomes in severe or difficult-to-treat asthma (English)

1 reference

2 December 2017

0 references

0 references

0 references

TENOR Study Group

1 reference

2 December 2017

Tmirah Haselkorn

1 reference

2 December 2017

June H Lee

series ordinal

1 reference

2 December 2017

David R Mink

series ordinal

1 reference

2 December 2017

Scott T Weiss

series ordinal

1 reference

2 December 2017

publication date

1 September 2008

1 reference

Annals of Allergy, Asthma & Immunology

2 December 2017

published in

1 reference

2 December 2017

volume

101

1 reference

2 December 2017

1 reference

2 December 2017

page(s)

256-263

1 reference

2 December 2017

cites work

Epidemiology of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960490-5

7 January 2021

The widening black/white gap in asthma hospitalizations and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960490-5

7 January 2021

Racial differences in physiologic parameters related to asthma among middle-class children

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960490-5

7 January 2021

Ethnicity and skin test reactivity to aeroallergens among asthmatic children in Connecticut

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960490-5

7 January 2021

Race and sex differences in consistency of care with national asthma guidelines in managed care organizations

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960490-5

7 January 2021

Asthma morbidity and treatment in the Chicago metropolitan area: one decade after national guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960490-5

7 January 2021

The relation of socioeconomic factors and racial/ethnic differences in US asthma mortality

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960490-5

7 January 2021

Modifiable barriers to adherence to inhaled steroids among adults with asthma: it's not just black and white

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960490-5

7 January 2021

Reducing disparities in asthma care: priorities for research--National Heart, Lung, and Blood Institute workshop report

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960490-5

7 January 2021

Applying epidemiologic concepts of primary, secondary, and tertiary prevention to the elimination of racial disparities in asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960490-5

7 January 2021

Risk factors for asthma morbidity and mortality in a large metropolitan city

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960490-5

7 January 2021

Racial/ethnic variation in asthma status and management practices among children in managed medicaid

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960490-5

7 January 2021

Acute asthma among adults presenting to the emergency department: the role of race/ethnicity and socioeconomic status

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960490-5

7 January 2021

The influence of health disparities on individual patient outcomes: what is the link between genes and environment?

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960490-5

7 January 2021

Airway responsiveness in young black and white women

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960490-5

7 January 2021

The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960490-5

7 January 2021

Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960490-5

7 January 2021

beta2-Adrenergic receptor haplotypes in mild, moderate and fatal/near fatal asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960490-5

7 January 2021

Design and baseline characteristics of the epidemiology and natural history of asthma: Outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960490-5

7 January 2021

Impact of patient socioeconomic status on physician profiles: a comparison of census-derived and individual measures

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960490-5

7 January 2021

Using Global Initiative for Asthma guidelines to assess asthma severity in populations

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960490-5

7 January 2021

Association of asthma control with health care utilization and quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960490-5

7 January 2021

Development and validation of the Mini Asthma Quality of Life Questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960490-5

7 January 2021

The validity and reproducibility of a work productivity and activity impairment instrument

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960490-5

7 January 2021

Assessing productivity loss and activity impairment in severe or difficult-to-treat asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960490-5

7 January 2021

Standardization of Spirometry, 1994 Update. American Thoracic Society

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960490-5

7 January 2021

Spirometric reference values from a sample of the general U.S. population

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960490-5

7 January 2021

Prevalence and trends in overweight among US children and adolescents, 1999-2000

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960490-5

7 January 2021

Prevalence of obesity in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960490-5

7 January 2021

Asthma is associated with weight gain in females but not males, independent of physical activity

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960490-5

7 January 2021

Asthma and maternal body mass index are related to pediatric body mass index and obesity: results from the Third National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960490-5

7 January 2021

Association of being overweight with greater asthma symptoms in inner city black and Hispanic children

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960490-5

7 January 2021

Individual and neighborhood-level factors in predicting asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960490-5

7 January 2021

Identification of population subgroups of children and adolescents with high asthma prevalence: findings from the Third National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960490-5

7 January 2021

Asthma prevalence among US adults, 1998-2000: role of Puerto Rican ethnicity and behavioral and geographic factors

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960490-5

7 January 2021

Sociodemographic correlates of indoor allergen sensitivity among United States children.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960490-5

7 January 2021

Variation in total and specific IgE: effects of ethnicity and socioeconomic status

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960490-5

7 January 2021

Total serum IgE levels in a large cohort of patients with severe or difficult-to-treat asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960490-5

7 January 2021

High prevalence of skin test positivity in severe or difficult-to-treat asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960490-5

7 January 2021

Determinants of quality of life among people with asthma: findings from the Behavioral Risk Factor Surveillance System

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960490-5

7 January 2021

Racial differences in emergency department use persist despite allergist visits and prescriptions filled for antiinflammatory medications

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960490-5

7 January 2021

Emergency department visits by urban African American children with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960490-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960490-5

7 January 2021

Relationship between asthma drug therapy patterns and healthcare utilization

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960490-5

7 January 2021

Racial differences in T-lymphocyte response to glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960490-5

7 January 2021

The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960490-5

7 January 2021

Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960490-5

7 January 2021

10.1016/S1081-1206(10)60490-5

Identifiers

DOI

1 reference

2 December 2017

1 reference